Cargando…

Benefits of PDE5 inhibition in patients with diastolic heart failure

Detalles Bibliográficos
Autor principal:	Guazzi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363197/ http://dx.doi.org/10.1186/1471-2210-11-S1-O6

Ejemplares similares

Novel mechanisms of anti-hypertrophic effects from PDE5A inhibition
por: Kass, David A, et al.
Publicado: (2009)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

cGMP-Prkg1 signaling PDE5 inhibition shelter cochlear hair cells and hearing function
por: Knipper, Marlies, et al.
Publicado: (2013)

MRI feature tracking strain profiles distinguish patients with left ventricular systolic and diastolic dysfunction with and without clinical heart failure
por: Choudhary, Naila, et al.
Publicado: (2016)

Diastolic preparation for left ventricular ejection - A marker of inefficiency of the failing heart
por: Eriksson, Jonatan, et al.
Publicado: (2011)

Diffusion MRI tractography of the human heart In Vivo at end-diastole and end-systole
por: Mekkaoui, Choukri, et al.
Publicado: (2012)

Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
por: Rybalkin, Sergei D, et al.
Publicado: (2013)

Comprehensive evaluation of diastolic function with MRI
por: Richard, Thompson, et al.
Publicado: (2009)

Molecular targets for PDE inhibitor-mediated improvement of cardiac dysfunction in the mdx mouse?
por: Adamo, Candace M, et al.
Publicado: (2011)

Acute effects of phosphodiesterase 5 (PDE5) inhibition, ANP and NO on epididymal contractility are preserved despite chronic PDE5 exposure
por: Mietens, Andrea, et al.
Publicado: (2011)

Acute heart failure syndromes
por: Gheorghiade, Mihai
Publicado: (2009)

Left ventricular torsional hysteresis in patients with hypertension: a global parameter for diastolic function
por: Schiros, Chun, et al.
Publicado: (2013)

Assessment of left ventricular systolic and diastolic function in patients with sarcoidosis with and without cardiac involvement by magnetic resonance feature tracking at 1.5T: a follow up study
por: Dabir, Darius, et al.
Publicado: (2016)

Surgical ventricular restoration in patients LV aneurisms and congestive heart failure
por: Baev, B, et al.
Publicado: (2013)

Biventricular centrimag support for patients in end-stage biventricular heart failure
por: Horvath, V, et al.
Publicado: (2013)

Polymorphism in HIV-1 dependency factor PDE8A affects gene expression and HIV-1 replication in primary macrophages
por: Booiman, Thijs, et al.
Publicado: (2011)

Skeletal muscle ATP kinetics during exercise in patients with systolic heart failure
por: Panjrath, Gurusher S, et al.
Publicado: (2013)

Integrated analysis of diastolic, systolic and pulmonary vascular function using MRI guided catheterization
por: Schmitt, Boris, et al.
Publicado: (2009)

Predictors of subclinical diastolic dysfunction measured by MRI: multi-ethnic study of atherosclerosis (MESA)
por: Qadir, Sadia, et al.
Publicado: (2009)

Diastolic function from tagged MRI and myocardial fibrosis: the Multi-Ethnic study of Atherosclerosis (MESA)
por: Venkatesh, Bharath Ambale, et al.
Publicado: (2013)

Echocardiographic evaluation of changes in diastolic dysfunction after CABG surgery, effect of novel therapy with Ivabradine
por: Panayotova, D, et al.
Publicado: (2013)

Mt Everest trek causes impaired cardiac high energy phosphate metabolism and diastolic impairment
por: Holloway, Cameorn J, et al.
Publicado: (2009)

Decreased exercise capacity in ‘asymptomatic’ patients late after relief of severe pulmonary stenosis and moderate restenosis: evidence for diastolic dysfunction
por: Romeih, Soha, et al.
Publicado: (2012)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

Prognostic CMR parameters for heart failure and arrhythmias in large cohort of well treated thalssemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Quantifying passive myocardial stiffness and wall stress in heart failure patients using personalized ventricular mechanics
por: Wang, Zhinuo Jenny, et al.
Publicado: (2016)

Internal Flow Fraction discriminates patients with dyssynchronous heart failure from age and sex-matched controls
por: Fornwalt, Brandon K, et al.
Publicado: (2009)

The effect of myocardial fibrosis on left ventricular diastolic function assessed by non-invasive cardiac magnetic resonance and echocardiography
por: Sani, Zahra Alizadeh, et al.
Publicado: (2012)

Cellular hypertrophy occurs before interstitial fibrosis in pressure-overload heart failure
por: Shah, Ravi, et al.
Publicado: (2013)

A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
por: Franciosi, Luigi, et al.
Publicado: (2013)

Cardiac MRI underlines the role of BNP and hematologic parameters as heart failure markers in patients with Ebstein's anomaly of the tricuspid valve
por: Steinmetz, Michael, et al.
Publicado: (2014)

Cardiac mechanical activation mapping in heart failure patients with left bundle branch block using cine DENSE MRI
por: Auger Cornejo, Daniel A, et al.
Publicado: (2015)

Quantification of pulmonary edema in heart failure using MRI: invasive validation and evaluation in HFpEF and HFrEF patients
por: Thompson, Richard B, et al.
Publicado: (2016)

Vortex formation ratio in heart failure compared to healthy volunteers at rest and during exercise
por: Kanski, Mikael, et al.
Publicado: (2013)

Cost benefits of cardiovascular magnetic resonance imaging and angiography performed earlier in the diagnostic assessment of neonatal complex congenital heart disease
por: Renella, Pierangelo, et al.
Publicado: (2014)

Use of miniaturized extracorporeal circulation for implanting left ventricular assist devices in high-risk end-stage heart failure patients
por: Antonitsis, P, et al.
Publicado: (2013)

Right atrial volume indexed by cardiovascular magnetic resonance as a predictor of mortality in patients with heart failure with reduced ejection fraction
por: Ivanov, Alexander, et al.
Publicado: (2016)

LCZ696, an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure and hypertension
por: Lefkowitz, Martin P
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kb37h69v1rb5cdpqlcgs529f9d